5:53 PM
Aug 15, 2017
 |  BC Extra  |  Company News

Stanford, Takeda partner for drug discovery

Stanford University and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) are forming the Stanford Alliance for Innovative Medicines, or Stanford AIM, to accelerate commercialization of therapeutic discoveries made in the university's labs.

The partners will begin...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >